Blog

Scientific problem solving in action
Here, we share insights, updates, and perspectives from across our company—from scientific innovation and sustainability to team culture and industry trends. Get a deeper look at how we think, work and grow at ten23 health, always guided by our purpose of serving Patients, People and the Planet by helping develop and deliver better therapies.

 

International Day of Women in Science

On the occasion of the 2026 International Day of Women in Science, taking place each year in February 11th, we proudly spotlight Eva Potthoff, MSAT Circle Lead at ten23 health.

2025 FDA approvals: Formulation Outlook

In 2025, the US FDA has approved 46 novel drugs that year. Amongst those, 12 biologics—accounting roughly 25% of total approvals—include antibody-drug conjugates (ADCs), fusion proteins, and both mono- and bispecific monoclonal antibodies. While oncology remained the primary focus for the approved biologics, recent approvals also span a diverse range of therapeutic areas, including pulmonary, cardiovascular, renal, immunology, and neurology.

The Art of Integrated Drug Development and Manufacturing

Integrated development improves speed, quality, and scalability in drug production. This article highlights how ten23 health streamlines the entire process—from molecule characterization to commercial manufacturing—under one roof.

Sterile solutions, built differently.

Looking for a partnership powered by purpose? 

We're ready for what comes next. 

Let's connect